problem in central and east European countries
This chapter makes use of the recent information made available
through the Phare multi-beneficiary drugs programme. Currently,
partnership between the EMCDDA and the candidate countries is in
a transition period during which direct technical cooperation will
be expanded to further develop the institutional basis for national
drug information systems, to consolidate relations and to establish
permanent structural links.